NS-062 is an orally active, irreversible targeted covalent inhibitor for EGFR , and exhibits antiproliferative efficacy in drug-resistant double mutated H1975 cell with an IC 50 of 0.19 μM. NS-062 exhibits antitumor efficacy in mouse H1975 xenograft model.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > EGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.